Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2016 1
2017 1
2021 1
2024 1
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study.
De Corso E, Corbi M, De Maio G, Mastrapasqua R, Montuori C, D'Auria LM, Rizzuti A, Spanu C, Pisciottano S, Dâ Agostino G, Pacilli MC, Ortolan A, Rizzi A, Galli J. De Corso E, et al. Among authors: pacilli mc. Rhinology. 2025 Dec 1;63(6):667-675. doi: 10.4193/Rhin25.121. Rhinology. 2025. PMID: 40631514
Blood and local nasal eosinophilia in chronic rhinosinusitis with nasal polyps: prevalence and correlation with severity of disease.
De Corso E, Corbò M, Montuori C, Furno D, Seccia V, Di Cesare T, Pipolo C, Baroni S, Mastrapasqua R, Rizzuti A, D'Agostino G, D'Auria LM, Pacilli MC, Galli J. De Corso E, et al. Among authors: pacilli mc. Acta Otorhinolaryngol Ital. 2025 Feb;45(1):39-46. doi: 10.14639/0392-100X-N2877. Acta Otorhinolaryngol Ital. 2025. PMID: 40099445 Free PMC article.
Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage.
De Corso E, Montuori C, Pipolo C, La Mantia I, Pasquini E, Ghidini A, Seccia V, Ottaviano G, Cantone E, Dané G, Garzaro M, Fadda GL, Torretta S, Anastasi F, Canevari FRM, Pagella F, Lucidi D, Cavaliere C, Pagliuca G, Maffei M, Bussu F, Corbò M, D Auria LM, De Maio G, Loperfido A, Gallo S, D Agostino G, Giannarelli D, Galli J; DUPIREAL Italian Study Group. De Corso E, et al. Allergy. 2026 Feb;81(2):388-401. doi: 10.1111/all.70032. Epub 2025 Aug 30. Allergy. 2026. PMID: 40884177
Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL Population.
De Corso E, Montuori C, Cantone E, Pipolo GC, Lucidi D, Pasquini E, La Mantia I, Mastrapasqua RF, De Maio G, Fadda GL, Ottaviano G, Rosso C, Alicandri-Ciufelli M, Seccia V, Ghidini A, Paolo R, Dané G, Pagella F, Sovardi F, Corbo M, Pisciottano S, D'Auria LM, Bussu F, Galli J; Dupireal Italian Study Group. De Corso E, et al. Clin Otolaryngol. 2026 Mar;51(2):285-295. doi: 10.1111/coa.70060. Epub 2025 Nov 19. Clin Otolaryngol. 2026. PMID: 41261359
n-3 fatty acids in patients with multiple cardiovascular risk factors.
Risk and Prevention Study Collaborative Group; Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R. Risk and Prevention Study Collaborative Group, et al. N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409. N Engl J Med. 2013. PMID: 23656645 Free article. Clinical Trial.
11 results